These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7776087)

  • 41. Procalcitonin as a marker of serious bacterial infections in febrile children younger than 3 years old.
    Mahajan P; Grzybowski M; Chen X; Kannikeswaran N; Stanley R; Singal B; Hoyle J; Borgialli D; Duffy E; Kuppermann N
    Acad Emerg Med; 2014 Feb; 21(2):171-9. PubMed ID: 24673673
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone.
    Baskin MN; O'Rourke EJ; Fleisher GR
    J Pediatr; 1992 Jan; 120(1):22-7. PubMed ID: 1731019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine.
    Carstairs KL; Tanen DA; Johnson AS; Kailes SB; Riffenburgh RH
    Ann Emerg Med; 2007 Jun; 49(6):772-7. PubMed ID: 17337092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fever phobia revisited: have parental misconceptions about fever changed in 20 years?
    Crocetti M; Moghbeli N; Serwint J
    Pediatrics; 2001 Jun; 107(6):1241-6. PubMed ID: 11389237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and hematologic features do not reliably identify children with unsuspected meningococcal disease.
    Kuppermann N; Malley R; Inkelis SH; Fleisher GR
    Pediatrics; 1999 Feb; 103(2):E20. PubMed ID: 9925866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis.
    Lee GM; Fleisher GR; Harper MB
    Pediatrics; 2001 Oct; 108(4):835-44. PubMed ID: 11581433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease.
    Wilimas JA; Flynn PM; Harris S; Day SW; Smith R; Chesney PJ; Rodman JH; Eguiguren JM; Fairclough DL; Wang WC
    N Engl J Med; 1993 Aug; 329(7):472-6. PubMed ID: 8332152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the incidence of occult bacteremia among children with fever of unknown origin.
    Berezin EN; Iazzetti MA
    Braz J Infect Dis; 2006 Dec; 10(6):396-9. PubMed ID: 17420912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management and outcomes of care of fever in early infancy.
    Pantell RH; Newman TB; Bernzweig J; Bergman DA; Takayama JI; Segal M; Finch SA; Wasserman RC
    JAMA; 2004 Mar; 291(10):1203-12. PubMed ID: 15010441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parents' utilities for outcomes of occult bacteremia.
    Bennett JE; Sumner W; Downs SM; Jaffe DM
    Arch Pediatr Adolesc Med; 2000 Jan; 154(1):43-8. PubMed ID: 10632249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of occult bacteremia in children aged 3 to 36 months presenting to the emergency department with fever in the postpneumococcal conjugate vaccine era.
    Wilkinson M; Bulloch B; Smith M
    Acad Emerg Med; 2009 Mar; 16(3):220-5. PubMed ID: 19133844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of Occult Bacteremia in Infants With Very High Fever Without a Source.
    Gangoiti I; Rodriguez E; Zubizarreta A; Benito J; Mintegi S
    Pediatr Infect Dis J; 2018 Nov; 37(11):e271-e273. PubMed ID: 29462106
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Occult bacteremia etiology following the introduction of 13-valent pneumococcal conjugate vaccine: a multicenter study in Spain.
    Hernández-Bou S; Gómez B; Mintegi S; García-García JJ;
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1449-1455. PubMed ID: 29736610
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid antigen assay for the diagnosis of pneumococcal bacteremia in children: a preliminary study.
    Neuman MI; Harper MB
    Ann Emerg Med; 2002 Oct; 40(4):399-404. PubMed ID: 12239495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of C-reactive protein velocity in the diagnosis of early bacterial infections in children after cardiac surgery.
    Nahum E; Livni G; Schiller O; Bitan S; Ashkenazi S; Dagan O
    J Intensive Care Med; 2012; 27(3):191-6. PubMed ID: 21561990
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia.
    Baorto EP; Aquino VM; Mullen CA; Buchanan GR; DeBaun MR
    Cancer; 2001 Aug; 92(4):909-13. PubMed ID: 11550165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood cultures in private pediatric practice: an eleven-year experience.
    Baron MA; Fink HD; Cicchetti DV
    Pediatr Infect Dis J; 1989 Jan; 8(1):2-7. PubMed ID: 2922233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections.
    Levine DA; Platt SL; Dayan PS; Macias CG; Zorc JJ; Krief W; Schor J; Bank D; Fefferman N; Shaw KN; Kuppermann N;
    Pediatrics; 2004 Jun; 113(6):1728-34. PubMed ID: 15173498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Occult pneumococcal bacteremia: a review.
    Joffe MD; Alpern ER
    Pediatr Emerg Care; 2010 Jun; 26(6):448-54; quiz 455-7. PubMed ID: 20531134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.